The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksDJAN.L Regulatory News (DJAN)

  • There is currently no data for DJAN

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Form 8 (OPD) - Daejan Holdings PLC

5 Mar 2020 16:48

RNS Number : 1997F
Daejan Holdings PLC
05 March 2020
 

FORM 8 (OPD)

 

PUBLIC OPENING POSITION DISCLOSURE BY A PARTY TO AN OFFER

Rules 8.1 and 8.2 of the Takeover Code (the "Code")

 

1. KEY INFORMATION

 

(a) Full name of discloser:

DAEJAN HOLDINGS PLC

(b) Owner or controller of interests and short positions disclosed, if different from 1(a):

The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named.

N/A

(c) Name of offeror/offeree in relation to whose relevant securities this form relates:

Use a separate form for each offeror/offeree

OFFEREE - DAEJAN HOLDINGS PLC

(d) Is the discloser the offeror or the offeree?

OFFEREE

(e) Date position held:

The latest practicable date prior to the disclosure

4 March 2020

(f) In addition to the company in 1(c) above, is the discloser making disclosures in respect of any other party to the offer?

If it is a cash offer or possible cash offer, state "N/A"

N/A

 

 

2. POSITIONS OF THE PARTY TO THE OFFER MAKING THE DISCLOSURE

 

If there are positions or rights to subscribe to disclose in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 2(a) or (b) (as appropriate) for each additional class of relevant security.

 

(a) Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates

 

Class of relevant security:

 

 

 

Interests

Short positions

Number

%

Number

%

(1) Relevant securities owned and/or controlled:

Nil

0

Nil

0

(2) Cash-settled derivatives:

 

Nil

0

Nil

0

(3) Stock-settled derivatives (including options) and agreements to purchase/sell:

Nil

0

Nil

0

 

TOTAL:

Nil

0

Nil

0

 

All interests and all short positions should be disclosed.

 

Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).

 

Details of any securities borrowing and lending positions or financial collateral arrangements should be disclosed on a Supplemental Form 8 (SBL).

 

(b) Rights to subscribe for new securities

 

Class of relevant security in relation to which subscription right exists:

None

Details, including nature of the rights concerned and relevant percentages:

None

 

 

3. POSITIONS OF PERSONS ACTING IN CONCERT WITH THE PARTY TO THE OFFER MAKING THE DISCLOSURE

 

Details of any interests, short positions and rights to subscribe (including directors' and other employee options) of any person acting in concert with the party to the offer making the disclosure:

 

(a) Interests held by directors of Daejan Holdings plc not acting in concert with the Offeror and their close relatives and related trusts

Class of relevant security: Ordinary shares of 25 pence each

 

Name

Number of ordinary shares of 25p each

Percentage of issued share capital of Daejan Holdings plc*

Solly Benaim

Nil

0

Sander Srulowitz

Nil

0

TOTAL

Nil

0

*Figures are rounded up to 2 decimal places

 

(b) Interests held by connected advisers of Daejan Holdings Plc

 

Lazard & Co. Limited

 

Class of relevant security

Ordinary shares of 25p each

Interests

Short Positions

Number

%

Number

%

(1) Relevant securities owned and/or controlled:

Nil

0

Nil

0

(2) Cash-settled derivatives:

Nil

0

Nil

0

(3) Stock-settled derivatives (including options) and agreements to purchase/sell:

Nil

0

Nil

0

 

Nplus1 Singer Capital Markets Limited

 

 

Class of relevant security

Ordinary shares of 25p each

Interests

Short Positions

Number

%

Number

%

(1) Relevant securities owned and/or controlled:

Nil

0

Nil

0

(2) Cash-settled derivatives:

Nil

0

Nil

0

(3) Stock-settled derivatives (including options) and agreements to purchase/sell:

Nil

0

Nil

0

 

 

 

Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).

 

Details of any securities borrowing and lending positions or financial collateral arrangements should be disclosed on a Supplemental Form 8 (SBL).

 

4. OTHER INFORMATION

 

(a) Indemnity and other dealing arrangements

 

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the party to the offer making the disclosure or any person acting in concert with it:

Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state "none"

 

None

 

 

(b) Agreements, arrangements or understandings relating to options or derivatives

 

Details of any agreement, arrangement or understanding, formal or informal, between the party to the offer making the disclosure, or any person acting in concert with it, and any other person relating to:

(i) the voting rights of any relevant securities under any option; or

(ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:

If there are no such agreements, arrangements or understandings, state "none"

 

None

 

 

(c) Attachments

 

Are any Supplemental Forms attached?

 

Supplemental Form 8 (Open Positions)

NO

Supplemental Form 8 (SBL)

NO

 

 

Date of disclosure:

5 March 2020

Contact name:

M R M Jenner

Company Secretary

Telephone number:

020 7836 1555

 

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service.

 

The Panel's Market Surveillance Unit is available for consultation in relation to the Code's disclosure requirements on +44 (0)20 7638 0129.

 

The Code can be viewed on the Panel's website at www.thetakeoverpanel.org.uk.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
FEEJAMFTMTIMBMM
Date   Source Headline
12th Feb 20134:37 pmRNSPrice Monitoring Extension
29th Nov 201210:30 amRNSInterim Results
16th Aug 20127:00 amRNSInterim Management Statement
11th Jul 201210:30 amRNSFinal Results
16th Feb 20121:00 pmRNSInterim Management Statement
30th Nov 201111:31 amRNSInterim Results
17th Aug 201110:55 amRNSInterim Management Statement
13th Jul 201112:30 pmRNSFinal Results
10th Feb 20119:00 amRNSInterim Management Statement
25th Nov 201011:37 amRNSInterim Results
28th Oct 20102:45 pmRNSAnnual Information Update
17th Aug 201011:10 amRNSInterim Management Statement
7th Jul 20102:33 pmRNSFinal Results
28th May 201011:37 amRNSNotification of Transfer
11th Feb 20107:00 amRNSInterim Management Statement
27th Nov 20094:35 pmRNSPrice Monitoring Extension
24th Nov 20093:37 pmRNSDirector/PDMR Shareholding
20th Nov 200912:00 pmRNSInterim Results
30th Sep 20094:35 pmRNSPrice Monitoring Extension
8th Sep 20099:33 amRNSAnnual Information Update
7th Sep 20092:23 pmRNSDirector/PDMR Shareholding
17th Aug 200912:53 pmRNSInterim Management Statement
15th Jul 20093:38 pmRNSPreliminary Results
11th May 20094:40 pmRNSSecond Price Monitoring Extn
11th May 20094:35 pmRNSPrice Monitoring Extension
23rd Apr 20094:35 pmRNSPrice Monitoring Extension
2nd Mar 20094:37 pmRNSPrice Monitoring Extension
13th Feb 20094:40 pmRNSSecond Price Monitoring Extn
13th Feb 20094:35 pmRNSPrice Monitoring Extension
11th Feb 200910:42 amRNSInterim Management Statement
23rd Jan 200911:14 amRNSDirector/PDMR Shareholding
16th Jan 20094:36 pmRNSPrice Monitoring Extension
31st Dec 200812:41 pmRNSSecond Price Monitoring Extn
31st Dec 200812:38 pmRNSPrice Monitoring Extension
26th Nov 200811:59 amRNSInterim Results
21st Nov 20084:49 pmRNSSecond Price Monitoring Extn
21st Nov 20084:40 pmRNSPrice Monitoring Extension
13th Nov 20084:41 pmRNSSecond Price Monitoring Extn
13th Nov 20084:37 pmRNSPrice Monitoring Extension
12th Nov 20084:38 pmRNSPrice Monitoring Extension
4th Nov 20084:37 pmRNSPrice Monitoring Extension
3rd Sep 20087:00 amRNSAnnual Information Update
2nd Sep 20083:57 pmRNSInterim Management Statement
10th Jul 200811:58 amRNSFinal Results
31st Mar 20084:35 pmRNSPrice Monitoring Extension
19th Feb 20084:42 pmRNSInterests in Shares
19th Feb 20084:42 pmRNSTransfer of Shares
19th Feb 20084:35 pmRNSInterests in Shares
11th Feb 200812:47 pmRNSInterim Management Statement
17th Dec 20074:35 pmRNSPrice Monitoring Extension

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.